Targeted therapy
December 15, 2021
This trial is for patients who have cancer cells still in the blood or bone marrow after approximately one year of lenalidomide maintenance therapy following a stem cell transplant
December 15, 2021
This study is exploring a new treatment option for patients with advanced (metastatic) non-small cell lung cancer that has the EGFR gene mutation
December 15, 2021
Dr. Michael Atkins, a medical oncologist who specializes in melanoma, talks about the results of the DREAMseq trial and how the information will hopefully extend life for more patients with advanced melanoma
June 24, 2021
Each arm of NCI-MATCH—and every patient who participates—provide valuable information on potential cancer treatments.